News

Cookie Notification

We use cookies to collect information about how our website is used and to improve the visitor experience. You can change your browser's cookie settings at any time. Please review our privacy policy for more information. OK

Media Contact

Stephen Schultz
VP Investor Relations (U.S.)
T: 917-280-2424 / 401 500 6570
sschultz@gwpharm.com
 

Recent Press Releases

Mar 19, 2013
Porton Down, UK, 19 March 2013: GW Pharmaceuticals plc (AIM: GWP, "GW" or the “Company”), the biopharmaceutical company focused on discovering, developing and commercialising novel therapeutics from its proprietary
Mar 19, 2013
Porton Down, UK, 19 March 2013: GW Pharmaceuticals plc (AIM: GWP, “GW”), the specialty pharmaceutical company focused on cannabinoid science, today provides an update on pricing negotiations in Germ
Mar 19, 2013
Porton Down, UK; March 19 2013: GW Pharmaceuticals plc (AIM:GWP) today announced the appointment of Stephen D. Schultz to the new role of Vice President, Investor Relations. Mr.
Feb 19, 2013
Porton Down, UK; February 19 2013: GW Pharmaceuticals plc (AIM:GWP) today announces the appointment of Cabot Brown as a non-executive director with immediate effect.

Pages